Exploring Helium Ions’ Potential for Post-Mastectomy Left-Sided Breast Cancer Radiotherapy
Authors:
- Santa Gabriella BonaccorsiSBSanta Gabriella Bonaccorsi
- Thomas TessonnierTTThomas Tessonnier
- Line HoeltgenLHLine Hoeltgen
- Eva MeixnerEMEva Meixner
- Semi HarrabiSemi Harrabi
- Juliane Hörner-RieberJHJuliane Hörner-Rieber
- Thomas HabererTHThomas Haberer
- Amir AbdollahiAAAmir Abdollahi
- Jürgen DebusJDJürgen Debus
- Andrea MairaniAMAndrea Mairani
Open Access
Abstract
Proton therapy presents a promising modality for treating left-sided breast cancer due to its unique dose distribution. Helium ions provide increased conformality thanks to a reduced lateral scattering. Consequently, the potential clinical benefit of both techniques was explored. An explorative treatment planning study involving ten patients, previously treated with VMAT (Volumetric Modulated Arc Therapy) for 50 Gy in 25 fractions for locally advanced, node-positive breast cancer, was carried out using proton pencil beam therapy with a fixed relative biological effectiveness (RBE) of 1.1 and helium therapy with a variable RBE described by the mMKM (modified microdosimetric kinetic model). Results indicated that target coverage was improved with particle therapy for both the clinical target volume and especially the internal mammary lymph nodes compared to VMAT. Median dose value analysis revealed that proton and helium plans provided lower dose on the left anterior descending artery (LAD), heart, lungs and right breast than VMAT. Notably, helium therapy exhibited improved ipsilateral lung sparing over protons. Employing NTCP models as available in the literature, helium therapy showed a lower probability of grade ≤ 2 radiation pneumonitis (22% for photons, 5% for protons and 2% for helium ions), while both proton and helium ions reduce the probability of major coronary events with respect to VMAT.Keywords
Funding Information
- Erasmus+ (NA)
This publication has 62 references indexed in Scilit:
- Meta-analysis of incidence of early lung toxicity in 3-dimensional conformal irradiation of breast carcinomasRadiation Oncology, 2013
- Distribution of Coronary Artery Stenosis After Radiation for Breast CancerJournal of Clinical Oncology, 2012
- Dose to the Contralateral Breast From Radiotherapy and Risk of Second Primary Breast Cancer in the WECARE StudyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Concurrent trastuzumab with adjuvant radiotherapy in HER2-positive breast cancer patients: acute toxicity analyses from the French multicentric studyAnnals of Oncology, 2008
- Early clinical and radiological pulmonary complications following breast cancer radiation therapy: NTCP fit with four different modelsRadiotherapy and Oncology, 2007
- Microdosimetric Measurements and Estimation of Human Cell Survival for Heavy-Ion BeamsRadiation Research, 2006
- Long-term cardiac mortality after radiotherapy of breast cancer—application of the relative seriality modelBritish Journal of Radiology, 1996
- Tumour and Normal Tissue Responses to Fractionated Non-uniform Dose DeliveryInternational Journal of Radiation Biology, 1992
- Radiation-induced lung damage: dose-time fractionation considerationsRadiotherapy and Oncology, 1990
- Radiation-induced lung damage: dose-time-fractionation considerationsRadiotherapy and Oncology, 1989